Feature Channels

Grant Funded News

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 2-Sep-2014 4:00 PM EDT

Medicine

Channels:

Mice Study Shows Efficacy of New Gene Therapy Approach for Toxin Exposures

New research led by Charles Shoemaker, Ph.D., professor in the Department of Infectious Disease and Global Health at the Cummings School of Veterinary Medicine at Tufts University, shows that gene therapy may offer significant advantages in prevention and treatment of botulism exposure over current methods. The findings of the National Institutes of Health funded study appear in the August 29 issue of PLOS ONE.

View | Comment

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 4-Sep-2014 12:00 PM EDT

Medicine

Channels:

Keywords:

Assortativity Signatures of Transcription Factor Networks (TFNs) Contribute to Robustness

Dartmouth researchers explored the type and number of connections in transcription factor networks (TFNs) to evaluate the role assortativity plays on robustness in a study published in PLOS Computational Biology in August. The study found that the assortativity signature contributes to a network’s resilience against mutations.

View | Comment

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 4-Sep-2014 12:00 PM EDT

Medicine

Channels:

Keywords:

Drug Shows Promise Against Sudan Strain of Ebola in Mice

Researchers from Albert Einstein College of Medicine of Yeshiva University and other institutions have developed a potential antibody therapy for Sudan ebolavirus (SUDV), one of the two most lethal strains of Ebola. A different strain, the Zaire ebolavirus (EBOV), is now devastating West Africa. First identified in 1976, SUDV has caused numerous Ebola outbreaks (most recently in 2012) that have killed more than 400 people in total. The findings were reported in ACS Chemical Biology.

View | Comment

Medicine

Channels:

Keywords:

New Analysis of Old HIV Vaccines Finds Potentially Protective Immune Response

Applying the benefit of hindsight, researchers at Duke Medicine have reanalyzed the findings of two historic pediatric HIV vaccine trials with encouraging results. The vaccines had in fact triggered an antibody response -- now known to be associated with protection in adults -- that was previously unrecognized in the infants studied in the 1990s.

View | Comment

Medicine

Channels:

Keywords:

Wake Forest Baptist Cancer Center Awarded $18 Million by National Cancer Institute

Wake Forest Baptist Medical Center has received an $18 million, five-year grant from the National Cancer Institute’s Community Oncology Research Program (NCORP) to design and conduct community-based, multi-center screening, prevention and control cancer clinical trials.

View | Comment

Medicine

Channels:

Keywords:

Dosage of HIV Drug May Be Ineffective for Half of African-Americans

Many African-Americans may not be getting effective doses of the HIV drug maraviroc because they are more likely than European-Americans to inherit functional copies of a protein that speeds the removal of the drug from the body.

View | Comment

Medicine

Channels:

Keywords:

Dartmouth Pioneers Statistical Approach for Calculating Environmental Influences in Genome-Wide Association Study (GWAS) Results

Pathology_5358.jpg

Model allows researcher to remove false positive findings that plague modern research when many dozens of factors and their interactions are suggested to play a role in causing complex diseases.

View | Comment